This report contains market size and forecasts of Ondansetron HCL in global, including the following market information:
Global Ondansetron HCL Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ondansetron HCL Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Ondansetron HCL companies in 2021 (%)
The global Ondansetron HCL market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity ≥99.5% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ondansetron HCL include SUANFARMA, Dr. Reddy’s Laboratories, Teva, Anugraha Chemicals, Hikal, Dayaram Pharma, CTX, Cadila and SMS Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ondansetron HCL manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ondansetron HCL Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Ondansetron HCL Market Segment Percentages, by Type, 2021 (%)
Purity ≥99.5%
Purity ≥99.9%
Global Ondansetron HCL Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Ondansetron HCL Market Segment Percentages, by Application, 2021 (%)
Injection Solution
Tablet
Global Ondansetron HCL Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Ondansetron HCL Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ondansetron HCL revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ondansetron HCL revenues share in global market, 2021 (%)
Key companies Ondansetron HCL sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Ondansetron HCL sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
SUANFARMA
Dr. Reddy’s Laboratories
Teva
Anugraha Chemicals
Hikal
Dayaram Pharma
CTX
Cadila
SMS Pharmaceuticals
Fuan Pharmaceutical
Qilu Pharmaceutical